Gender Inequity in Pharma-Supported Inflammatory Bowel Disease Presentations: Shining a Light on Opportunities for Equality and Transparency in Medical Research
Historically, women have been underrepresented in surgical and procedural disciplines,1 including gastroenterology (GI). Over the past 6 decades, the number of women in these disciplines has increased, with women GI fellows accounting for 40.5% of the positions in 2023.2,3 Among GI subspecialties, inflammatory bowel disease (IBD) was selected by 26.5% of all woman GI physicians, compared with 18.9% of all men GI physicians, according to a 2021 study.4 This finding revealed the growing interest in IBD of young woman gastroenterologists; 33.5% of all IBD-GI fellowship positions were filled by women.
